The immune status is important in cancer patients. Tissue microarrays from 249 patients with soft tissue sarcomas were constructed. Immunohistochemistry was used to evaluate the CD3+, CD4+, CD8+, CD20+ and CD45+ lymphocytes in tumors. High density of CD20+ lymphocytes is an independent positive prognostic indicator for these patients. © 2012 Landes Bioscience.
CITATION STYLE
Sorbye, S. W., Kilvaer, T., Valkov, A., Donnem, T., Smeland, E., Al-Shibli, K., … Busund, L. T. (2012). High expression of CD20+ lymphocytes in soft tissue sarcomas is a positive prognostic indicator. OncoImmunology. https://doi.org/10.4161/onci.1.1.17825
Mendeley helps you to discover research relevant for your work.